Medical progress is transforming not only how long people live, but also the diseases they live with. A new population-based study from researchers at the Max Planck Institute for Demographic Research and the Karolinska Institute in Stockholm shows that Sweden’s health landscape has been reshaped in markedly different ways for heart attacks, strokes, hip fractures and cancer. While prevention has driven down the occurrence of several serious acute conditions, advances in diagnosis and treatment have allowed more people with cancer to survive, increasing the proportion of the population living with a history of the disease.
Published in The Lancet Regional Health – Europe, the study examined nationwide Swedish registry data covering people born between 1904 and 1960 and observed between 1987 and 2022. The researchers focused on adults between the ages of 60 and 90, calculating age-specific incidence rates, survival after diagnosis and disease prevalence. Incidence measures the rate at which new cases occur, while prevalence reflects how many people in a population are living with a condition at a given time. Together, these measures reveal whether changes in disease burden are being driven primarily by prevention, better survival or both.
The team analyzed new diagnoses of myocardial infarction, stroke, hip fracture and malignant cancer across successive birth cohorts. They also assessed the proportion of patients who survived for one and five years after diagnosis. To estimate prevalence at ages 70, 80 and 90, the researchers counted cases that occurred during earlier age intervals and whose patients survived until the relevant age. These values were then compared with the total population alive at the beginning of each age period, producing an age-specific picture of how disease histories have changed across generations.
The clearest declines appeared in heart attacks, strokes and hip fractures. For these conditions, the reduction in incidence was greater than the improvement in survival after diagnosis. In other words, fewer people were experiencing these events in the first place, and that preventive effect outweighed the growing number of patients surviving them. The result was a decrease in the prevalence of these diseases among later-born cohorts, despite major improvements in emergency medicine, hospital care and rehabilitation.
Heart attack trends illustrate the scale of the change. Among 75-year-old women, the incidence rate was approximately halved between the cohort born in 1920 and the cohort born in 1940. At the same time, the proportion surviving one year after a heart attack rose from 51 percent to 75 percent. This combination points to two distinct forms of medical progress: interventions that reduce the likelihood of a severe cardiovascular event, and treatments that improve the odds of surviving when one occurs. Prevention, however, had the stronger effect on the overall prevalence of heart attacks.
Similar patterns were observed for stroke and hip fracture. Improvements in cardiovascular risk management, public health, early detection and clinical treatment may all have contributed to fewer severe events. For hip fractures, changes in bone health, mobility, living conditions and fall prevention may also have played a role. Although the study does not assign the decline to one specific intervention, its cohort-based design demonstrates that the population-level consequences of prevention can be measured through the changing balance between incidence and survival.
Cancer followed a contrasting trajectory. The researchers found that new cancer cases increased across the generations studied, but survival after diagnosis also improved substantially. Better screening, earlier diagnosis, more precise classification of tumors, surgical advances, radiation therapy, targeted drugs and other treatments have helped many patients live longer. Because cancer incidence rose while survival improved, prevalence increased. More people were therefore living with a current or previous cancer diagnosis, creating a growing population need for long-term monitoring and follow-up care.
Among men, 17.3 percent of those born in 1912 had been diagnosed with cancer between the ages of 80 and 89. In the 1931 birth cohort, the corresponding figure reached 20.7 percent, an increase of roughly one-fifth. This does not mean that every individual in these groups was living with active cancer at the measured age; prevalence includes people whose disease histories extend into survivorship. The finding instead captures how improved survival and rising incidence can combine to produce a larger number of people requiring ongoing medical attention.
The researchers describe this relationship between new disease events and survival as the “incidence-survival gap.” Its direction differs by disease and helps explain why medical progress can reduce the prevalence of one condition while increasing that of another. For heart attacks, strokes and hip fractures, prevention has outpaced gains in survival, shrinking the affected population. For cancer, improved disease management has not offset the increase in new cases, expanding the number of people living with cancer histories. The authors say these changing disease trajectories will require increasingly integrated, interdisciplinary and patient-centered care.
Sweden is considered a low-mortality, high-income population, and its experience may provide a benchmark for other countries with comparable medical resources and demographic patterns. The exact timing and magnitude of these changes will vary according to healthcare systems, risk-factor exposure and the adoption of preventive technologies. Nevertheless, the study highlights a broad transformation in population health: fewer people are reaching old age after suffering certain catastrophic acute events, while more are surviving cancer and living with complex, long-term medical histories. The future of healthcare will therefore depend not only on preventing disease, but also on coordinating care for growing numbers of survivors.
Subject of Research: People
Article Title: Incidence, survival, and prevalence trends for myocardial infarction, stroke, hip fracture, and cancer across Swedish birth cohorts: a population-based register study
News Publication Date: 21-Jul-2026
Web References: https://doi.org/10.1016/j.lanepe.2026.101785
References: The Lancet Regional Health – Europe, “Incidence, survival, and prevalence trends for myocardial infarction, stroke, hip fracture, and cancer across Swedish birth cohorts: a population-based register study,” DOI: 10.1016/j.lanepe.2026.101785
Image Credits: MPIDR
Keywords: population health, medical progress, disease prevention, cancer survival, heart attack, stroke, hip fracture, Sweden, epidemiology, incidence, prevalence, survival, demography, aging, integrated care
Tags: aging population health trendscancer survival rateschanges in disease burden over timedemographic analysis of health dataepidemiology of strokehealthcare progress in cardiovascular diseasesheart attack preventionimpact of diagnosis and treatment improvementsinfluence of medical advances on disease prevalencelong-term health outcomes in Swedenpopulation-based disease incidence studyrise in cancer survivorship
